HIPK2 is downregulated in tumor cells compared with normal tissues in hepatocellular carcinoma20, esophageal squamous cell carcinoma21, urinary bladder cancer22, colorectal cancer23, and pancreatic cancer24. Here, HIPK2 is linked to neoplasm.